Back to search
Major Depressive Disorder With Anxious Distress
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Major Depressive Disorder With Anxious Distress trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Major Depressive Disorder With Anxious Distress trials you may qualify forThis is a randomized, parallel-group, double-blind, placebo-controlled, monotherapy study to evaluate the efficacy, safety, and tolerability of SPT-300 (GlyphAl…
Mental conditions and disorders (e.g. distress, depressive, anxiety, and eating disorders) are more prevalent in people with diabetes (PWD) and associated with…
This is an open-label, monotherapy, extension study to evaluate the safety and tolerability of SPT-300 (GlyphAllo) in adults with major depressive disorder (MDD…
Despite the growing prevalence of mental health disorders in low- and middle-income countries, significant barriers to seeking and accessing mental health servi…
The purpose of this study is to evaluate the efficacy and safety and tolerability of JNJ-42165279 in participants with major depressive disorder (MDD) with anxi…